SuperworthDare Bioscience market cap DARE
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Oct 23, 2026
- $9.9M
- Highest close in our data
- $208.9M
- Mar 2015
Dare Bioscience is worth $9.9M at the close on Oct 23, 2026, at $0.65 a share.
That is down 65% over the last year and down 90% over five years.
Its highest close in our data was $208.9M in Mar 2015.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $9.9M | $9.9M | $43M | −68% |
| 2025 | $30.7M | $17M | $35.3M | +8% |
| 2024 | $28.5M | $23.6M | $54.2M | −7% |
| 2023 | $30.5M | $28.6M | $114.9M | −57% |
| 2022 | $70.4M | $70.4M | $143.5M | −54% |
| 2021 | $153.2M | $52.4M | $158.6M | +201% |
| 2020 | $50.9M | $13.7M | $57M | +272% |
| 2019 | $13.7M | $8.8M | $19.2M | +78% |
| 2018 | $7.7M | $5.7M | $16.2M | −41% |
| 2017 | $13.1M | $8.2M | $91.1M | −33% |
| 2016 | $19.4M | $18.1M | $108.6M | −75% |
| 2015 | $76.6M | $76.6M | $208.9M | −41% |
| 2014 | $129.8M | $72.2M | $139.5M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Dare Bioscience's size, closest first, today.
| Company | Market cap |
|---|---|
| DAREDare Bioscience | $9.9M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Dare Bioscience
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.